Maynard Um
-
-
-
-
-
-
-
ImmunityBio presents UK patient survey on bladder cancer treatment preferences
-
-
-
-
-
-
-
ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
ImmunityBio ALERT: $IBRX Investors Who Lost Money Should Contact Block & Leviton By May 26th To Potentially Recover Losses
-
-
-
-
-
-
-
ImmunityBio completes NK cell manufacturing programs with 74 subjects
-
-
-
-
-
-
-
Increasing unusual put option volume: FND BRBR XRX FSLY XLP LNC HBAN FEZ OKTA VICI VTRS IGV IBRX
-
-
-
-
-
-
-
Immunitybio Inc (IBRX) PT Raised to $10 at H.C. Wainwright
-
-
-
-
-
-
-
ImmunityBio reports progress in bladder cancer trial enrollment
-
466,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


